Recombinant Human PF-4

Recombinant Human PF-4

Product No.: P127

[product_table name="All Top" skus="P127"]

- -
- -
Alternate Names
Platelet Factor-4, Oncostatin A, Ironplact, CXCL4, MGC138298, SCYB4
Product Type
Recombinant Protein
Expression Host
E. coli Cells
Species
Human

- -
- -
Select Product Size
- -
- -

Background

Platelet factor 4 (PF4) is a small cytokine belonging to the CXC chemokine family that is also known as chemokine (C-X-C motif) ligand 4 (CXCL4). This chemokine is released from alpha-granules of activated platelets during platelet aggregation, and promotes blood coagulation by moderating the effects of heparin-like molecules. Due to these roles, it is predicted to play a role in wound repair and inflammation.1 PF4 is usually found in a complex with proteoglycan. PF4 is chemotactic for neutrophils, fibroblasts and monocytes, and interacts with a splice variant of the chemokine receptor CXCR3, known as CXCR3B.2
Platelet factor-4 is released from the alpha-granules of activated platelets and binds with high affinity to heparin. Its major physiologic role appears to be neutralization of heparin-like molecules on the endothelial surface of blood vessels, thereby inhibiting local antithrombin III activity and promoting coagulation. As a strong chemoattractant for neutrophils and fibroblasts, PF4 probably has a role in inflammation and wound repair.3 PF4 is the antigen in heparin-induced thrombocytopenia, an idiosyncratic autoimmune reaction to the administration of the anticoagulant heparin.4

Protein Details

Purity
>97% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.01EU/µg as determined by the LAL method
Biological Activity
The biological activity of Human PF-4 was determined by its ability to inhibit human FGF-basic-dependent proliferation of NR6R-3T3 fibroblasts (Rizzino, A., et al., 1988, Cancer Res. 48:4266; Thomas, K. et al., 1987, Methods Enzymol. 147:120; Watson, J.B. et al., 1994, J. Clin. Invest. 94:261). The expected ED<sub>50</sub> for this effect is typically 5 - 15 μg/ml.
Protein Accession No.
Amino Acid Sequence
eaeedgdlqc lcvkttsqvr prhitslevi kagphcptaq liatlkngrk icldlqaply kkiikklles
N-terminal Sequence Analysis
Glu32
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human PF4 is Mr 7.8 kDa.
Predicted Molecular Mass
7.8
Formulation
This recombinant protein was lyophilized from a 0.2 μm filtered solution in 25% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA).
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

References & Citations

1. Poncz, M. et al. (1990) Blood 76: 336
2. Romagnani, P. et al. (2003) J Exp Med. 197: 1537
3. Warkentin, TE. et al. (2007) N. Engl. J. Med. 356: 891

Certificate of Analysis

IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.